English, Article edition: Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine A. Brett Hauber; Ari Gnanasakthy; Edward H. Snyder; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/93548
Physical Description
  • article
Language
  • English

Edition details

Title
  • Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
Author
  • A. Brett Hauber
  • Ari Gnanasakthy
  • Edward H. Snyder
  • Mohan V. Bala
  • Anke Richter
  • Josephine A. Mauskopf
Physical Description
  • article
Notes
  • Alzheimer's disease, Antidementias, Cost analysis, Pharmacoeconomics, Rivastigmine
  • RePEc:wkh:phecon:v:18:y:2000:i:6:p:609-612b
  • Objective: To estimate savings in the cost of caring for patients with Alzheimer's disease (AD) during 6 months, 1 year and 2 years of treatment with rivastigmine. An intermediate objective was to estimate the relationship between disease progression and institutionalisation. Design and setting: We assessed the relationship between Mini-Mental State Examination (MMSE) score and institutionalisation using a piecewise Cox proportional hazard model. To estimate cost savings from treatments lasting 6 months, 1 year and 2 years, estimates of the probability of institutionalisation were integrated with data from two 6-month phase III clinical trials of rivastigmine and a hazard model of disease progression. Main outcome measures and results: Our data suggest that savings in the overall cost of caring for patients with mild and moderate AD can be as high as $US4839 per patient after 2 years of treatment. Furthermore, the probability of institutionalisation increases steadily as MMSE score falls. Among our study individuals, age, race, level of education and marital status were significant predictors of institutionalisation, whereas gender had little effect. Conclusions: Using rivastigmine to treat AD results in a delay in disease progression for patients who begin treatment during the mild or moderate stages of the disease. By delaying the probability that a patient will be institutionalised, the cost of caring for AD patients can be significantly reduced.
  • RePEc:wkh:phecon:v:17:y:2000:i:4:p:351-360
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment